We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$39.2B
AUM Growth
+$2.5B
Cap. Flow
+$1.83B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.25%
Holding
3,494
New
280
Increased
1,537
Reduced
1,324
Closed
255

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Financials 8.97%
3 Healthcare 8.75%
4 Industrials 7.19%
5 Consumer Staples 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGG icon
1
iShares Core US Aggregate Bond ETF
AGG
$137B
$1.14B 2.92%
10,588,914
+1,074,747
+11% +$118M
IWD icon
2
iShares Russell 1000 Value ETF
IWD
$81.3B
$811M 2.07%
7,241,532
+494,469
+7% +$53.5M
IWF icon
3
iShares Russell 1000 Growth ETF
IWF
$123B
$805M 2.05%
30,686,308
+2,539,964
+9% +$65.9M
EFA icon
4
iShares MSCI EAFE ETF
EFA
$76.1B
$659M 1.68%
11,408,129
+1,144,839
+11% +$66M
VOO icon
5
Vanguard S&P 500 ETF
VOO
$967B
$627M 1.6%
3,051,947
+536,302
+21% +$108M
AAPL icon
6
Apple
AAPL
$4.72T
$527M 1.35%
18,205,208
+956,608
+6% +$27.1M
MSFT icon
7
Microsoft
MSFT
$2.83T
$511M 1.31%
8,226,016
+493,643
+6% +$29.7M
VZ icon
8
Verizon
VZ
$183B
$446M 1.14%
8,352,186
+149,193
+2% +$7.46M
SPY icon
9
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$433M 1.1%
1,935,515
+536,117
+38% +$117M
MDY icon
10
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$401M 1.02%
1,328,384
+70,562
+6% +$20.4M
T icon
11
AT&T
T
$157B
$396M 1.01%
12,315,321
+553,582
+5% +$16.3M
JPM icon
12
JPMorgan Chase
JPM
$930B
$366M 0.94%
4,246,134
+273,394
+7% +$20.8M
IWM icon
13
iShares Russell 2000 ETF
IWM
$81.2B
$328M 0.84%
2,434,399
+236,356
+11% +$30.2M
XOM icon
14
ExxonMobil
XOM
$650B
$326M 0.83%
3,610,248
+68,630
+2% +$6M
JNJ icon
15
Johnson & Johnson
JNJ
$624B
$318M 0.81%
2,758,289
-66,829
-2% -$7.72M
CVX icon
16
Chevron
CVX
$387B
$314M 0.8%
2,669,473
+87,031
+3% +$9.48M
MRK icon
17
Merck
MRK
$322B
$292M 0.75%
5,203,181
+460,518
+10% +$27M
PG icon
18
Procter & Gamble
PG
$342B
$274M 0.7%
3,263,040
+44,340
+1% +$3.78M
MO icon
19
Altria Group
MO
$120B
$272M 0.7%
4,029,629
+310,974
+8% +$20M
ABBV icon
20
AbbVie
ABBV
$454B
$243M 0.62%
3,880,735
+893,454
+30% +$54.5M
PEP icon
21
PepsiCo
PEP
$184B
$242M 0.62%
2,312,816
+508,996
+28% +$53.3M
PFE icon
22
Pfizer
PFE
$143B
$240M 0.61%
7,793,356
+599,248
+8% +$18.3M
MCD icon
23
McDonald's
MCD
$187B
$229M 0.59%
1,883,078
+248,013
+15% +$29.1M
KO icon
24
Coca-Cola
KO
$349B
$227M 0.58%
5,465,883
+682,400
+14% +$28.4M
SDY icon
25
State Street SPDR S&P Dividend ETF
SDY
$21.6B
$222M 0.57%
2,595,067
+316,571
+14% +$26.6M

Similar funds

Raymond James & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Raymond James & Associates held 3,494 positions worth $39.2B, up 6.8% from $36.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $1.83B of net new capital in Q4 2016, opening 280 new positions and adding to 1,537 existing holdings. Its largest new stake was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 9.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $76.5M trimmed.

  • Raymond James & Associates's largest Q4 2016 buy was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2016, an estimated $118M increase.
  • Raymond James & Associates's biggest Q4 2016 reduction was Reynolds American Inc, cutting an estimated $76.5M.
  • Raymond James & Associates fully exited Amsurg Corp in Q4 2016, selling an estimated $29.2M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $39.2B portfolio in Q4 2016.
  • Raymond James & Associates opened 280 new positions and closed 255 in Q4 2016.
  • Raymond James & Associates's portfolio value rose 6.8% quarter-over-quarter to $39.2B.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.